Glabellar Lines

  • Botox 2021 report

    Botox 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 35 Pages The 5 Key Questions Addressed by this Report:...

  • Dysport 2021 report

    Dysport 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Xeomin 2021 report

    Xeomin 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 32 Pages The 5 Key Questions Addressed by this Report:...

  • Brineura 2020 report

    Brineura 2020 U.S. PROMOTIONAL AUDIT REPORT Published July 2021 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Eloctate 2020 report

    Eloctate 2020 U.S. PROMOTIONAL AUDIT REPORT Published July 2021 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Xeomin 2020 report

    Xeomin 2020 U.S. PROMOTIONAL AUDIT REPORT Published July 2021 • 33 Pages The 5 Key Questions Addressed by this Report:...

  • Botox 2019 report

    Botox 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 35 Pages The 5 Key Questions Addressed by this Report:...

  • Dysport 2019 report

    Dysport 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Xeomin 2019 report

    Xeomin 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 32 Pages The 5 Key Questions Addressed by this Report:...

  • Botox 2018 report

    Botox 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 31 Pages The 5 Key Questions Addressed by this Report:...

  • Dysport 2018 report

    Dysport 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 19 Pages The 5 Key Questions Addressed by this Report:...

  • Xeomin 2018 report

    Xeomin 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 32 Pages The 5 Key Questions Addressed by this Report:...